McLaughlin Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
McLaughlin Asset Management's LLY Position: Q2 2026 in Review
McLaughlin Asset Management increased its Eli Lilly (LLY) stake by 10% in Q2 2026, buying an estimated $443K and bringing the position to 4,581 shares worth $5.49M. The position accounts for 3.78% of the portfolio, ranked #5.
McLaughlin Asset Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- McLaughlin Asset Management held 4,581 shares of Eli Lilly worth $5.49M as of Q2 2026.
- McLaughlin Asset Management bought 434 Eli Lilly shares in Q2 2026, an estimated $443K.
- Eli Lilly made up 3.78% of McLaughlin Asset Management's portfolio in Q2 2026, its #5 holding.
- McLaughlin Asset Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
- 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on McLaughlin Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.